Analyst Ratings For Myokardia (NASDAQ:MYOK)
Today, BMO Capital Markets raised its price target on Myokardia (NASDAQ:MYOK) to per share.
Some recent analyst ratings include
- 12/12/2017-JPMorgan Chase & Co. initiated coverage with a Overweight rating.
- 8/7/2017-Wells Fargo & Co Reiterated Rating of Outperform.
Recent Insider Trading Activity For Myokardia (NASDAQ:MYOK)
Myokardia (NASDAQ:MYOK) has insider ownership of 33.40% and institutional ownership of 83.91%.
- On 3/5/2018 Anastasios Gianakakos, Insider, sold 3,000 with an average share price of $61.07 per share and the total transaction amounting to $183,210.00.
- On 2/26/2018 Anastasios Gianakakos, Insider, sold 5,000 with an average share price of $60.00 per share and the total transaction amounting to $300,000.00.
- On 2/5/2018 Anastasios Gianakakos, Insider, sold 3,000 with an average share price of $51.05 per share and the total transaction amounting to $153,150.00.
- On 1/12/2018 Joseph Lambing, Insider, sold 5,000 with an average share price of $50.00 per share and the total transaction amounting to $250,000.00.
- On 1/9/2018 Jake Bauer, Insider, sold 5,000 with an average share price of $45.00 per share and the total transaction amounting to $225,000.00.
- On 1/4/2018 Anastasios Gianakakos, Insider, sold 3,000 with an average share price of $41.70 per share and the total transaction amounting to $125,100.00.
- On 1/3/2018 Kevin P Starr, Director, sold 816,326 with an average share price of $42.00 per share and the total transaction amounting to $34,285,692.00.
Recent Trading Activity for Myokardia (NASDAQ:MYOK)
Shares of Myokardia closed the previous trading session at 55.12 up +0.97 1.80% with 58.20000076293945 shares trading hands.